nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—MAP2K1—Oncostatin M Signaling Pathway—TP53—meningioma	0.00263	0.00263	CbGpPWpGaD
Trametinib—MAP2K1—Senescence and Autophagy in Cancer—PTEN—meningioma	0.00262	0.00262	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—ERBB2—meningioma	0.0026	0.0026	CbGpPWpGaD
Trametinib—MAP2K2—Kit receptor signaling pathway—AKT1—meningioma	0.00256	0.00256	CbGpPWpGaD
Trametinib—MAP2K1—IL-1 signaling pathway—AKT1—meningioma	0.00254	0.00254	CbGpPWpGaD
Trametinib—MAP2K1—RANKL/RANK Signaling Pathway—AKT1—meningioma	0.00254	0.00254	CbGpPWpGaD
Trametinib—MAP2K1—Cardiac Hypertrophic Response—AKT1—meningioma	0.00254	0.00254	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CTSL—meningioma	0.00253	0.00253	CbGpPWpGaD
Trametinib—MAP2K2—Fc-epsilon receptor I signaling in mast cells—AKT1—meningioma	0.00249	0.00249	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—ERBB2—meningioma	0.00248	0.00248	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—ERBB2—meningioma	0.00245	0.00245	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—AP1B1—meningioma	0.00244	0.00244	CbGpPWpGaD
Trametinib—MAP2K2—PDGFR-beta signaling pathway—PTEN—meningioma	0.00244	0.00244	CbGpPWpGaD
Trametinib—MAP2K2—Endothelins—AKT1—meningioma	0.00243	0.00243	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—ERBB2—meningioma	0.00243	0.00243	CbGpPWpGaD
Trametinib—MAP2K1—Kit receptor signaling pathway—AKT1—meningioma	0.0024	0.0024	CbGpPWpGaD
Trametinib—MAP2K2—Oncostatin M Signaling Pathway—AKT1—meningioma	0.00237	0.00237	CbGpPWpGaD
Trametinib—MAP2K2—mTOR signaling pathway—AKT1—meningioma	0.00234	0.00234	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—ERBB2—meningioma	0.00234	0.00234	CbGpPWpGaD
Trametinib—MAP2K1—Fc-epsilon receptor I signaling in mast cells—AKT1—meningioma	0.00233	0.00233	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways in Glioblastoma—TP53—meningioma	0.00233	0.00233	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—ERBB2—meningioma	0.00232	0.00232	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—ERBB2—meningioma	0.00232	0.00232	CbGpPWpGaD
Trametinib—MAP2K2—EGF/EGFR Signaling Pathway—ERBB2—meningioma	0.00232	0.00232	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—ERBB2—meningioma	0.00231	0.00231	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—ERBB2—meningioma	0.0023	0.0023	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—ERBB2—meningioma	0.00229	0.00229	CbGpPWpGaD
Trametinib—MAP2K2—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—meningioma	0.00229	0.00229	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—AP1B1—meningioma	0.00228	0.00228	CbGpPWpGaD
Trametinib—MAP2K1—PDGFR-beta signaling pathway—PTEN—meningioma	0.00228	0.00228	CbGpPWpGaD
Trametinib—MAP2K1—Endothelins—AKT1—meningioma	0.00227	0.00227	CbGpPWpGaD
Trametinib—MAP2K2—Disease—AP1B1—meningioma	0.00225	0.00225	CbGpPWpGaD
Trametinib—MAP2K1—Oncostatin M Signaling Pathway—AKT1—meningioma	0.00222	0.00222	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—PTEN—meningioma	0.00221	0.00221	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—PDGFB—meningioma	0.0022	0.0022	CbGpPWpGaD
Trametinib—MAP2K1—TSH signaling pathway—AKT1—meningioma	0.00219	0.00219	CbGpPWpGaD
Trametinib—MAP2K1—mTOR signaling pathway—AKT1—meningioma	0.00219	0.00219	CbGpPWpGaD
Trametinib—MAP2K1—AGE/RAGE pathway—AKT1—meningioma	0.00219	0.00219	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—ERBB2—meningioma	0.00218	0.00218	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways in Glioblastoma—TP53—meningioma	0.00218	0.00218	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—ERBB2—meningioma	0.00217	0.00217	CbGpPWpGaD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—ERBB2—meningioma	0.00217	0.00217	CbGpPWpGaD
Trametinib—MAP2K1—BCR signaling pathway—AKT1—meningioma	0.00217	0.00217	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—ERBB2—meningioma	0.00216	0.00216	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—ERBB2—meningioma	0.00216	0.00216	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—ERBB2—meningioma	0.00216	0.00216	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—ERBB2—meningioma	0.00216	0.00216	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—ERBB2—meningioma	0.00215	0.00215	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—ERBB2—meningioma	0.00215	0.00215	CbGpPWpGaD
Trametinib—MAP2K1—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—meningioma	0.00214	0.00214	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—ERBB2—meningioma	0.00213	0.00213	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—PTEN—meningioma	0.00212	0.00212	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—ERBB2—meningioma	0.00212	0.00212	CbGpPWpGaD
Trametinib—MAP2K2—Leptin signaling pathway—AKT1—meningioma	0.00211	0.00211	CbGpPWpGaD
Trametinib—MAP2K1—Disease—AP1B1—meningioma	0.00211	0.00211	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—PTEN—meningioma	0.00209	0.00209	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—PTEN—meningioma	0.00207	0.00207	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—PDGFB—meningioma	0.00206	0.00206	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—ERBB2—meningioma	0.00205	0.00205	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—ERBB2—meningioma	0.00203	0.00203	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—ERBB2—meningioma	0.00203	0.00203	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—ERBB2—meningioma	0.00203	0.00203	CbGpPWpGaD
Trametinib—MAP2K2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—meningioma	0.00201	0.00201	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—ERBB2—meningioma	0.00201	0.00201	CbGpPWpGaD
Trametinib—MAP2K2—Insulin Signaling—PTEN—meningioma	0.002	0.002	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—PTEN—meningioma	0.00199	0.00199	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—ERBB2—meningioma	0.00199	0.00199	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—PTEN—meningioma	0.00198	0.00198	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—PTEN—meningioma	0.00198	0.00198	CbGpPWpGaD
Trametinib—MAP2K2—EGF/EGFR Signaling Pathway—PTEN—meningioma	0.00198	0.00198	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—ERBB2—meningioma	0.00198	0.00198	CbGpPWpGaD
Trametinib—MAP2K1—Leptin signaling pathway—AKT1—meningioma	0.00198	0.00198	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—PTEN—meningioma	0.00197	0.00197	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways in Glioblastoma—AKT1—meningioma	0.00197	0.00197	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—PTEN—meningioma	0.00196	0.00196	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—PTEN—meningioma	0.00195	0.00195	CbGpPWpGaD
Trametinib—MAP2K2—MicroRNAs in cardiomyocyte hypertrophy—AKT1—meningioma	0.00193	0.00193	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—ERBB2—meningioma	0.00192	0.00192	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—ERBB2—meningioma	0.00191	0.00191	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.00191	0.00191	CbGpPWpGaD
Trametinib—MAP2K1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—meningioma	0.00188	0.00188	CbGpPWpGaD
Trametinib—MAP2K1—Insulin Signaling—PTEN—meningioma	0.00187	0.00187	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—PTEN—meningioma	0.00186	0.00186	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—PTEN—meningioma	0.00185	0.00185	CbGpPWpGaD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—PTEN—meningioma	0.00185	0.00185	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—PTEN—meningioma	0.00185	0.00185	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—PTEN—meningioma	0.00185	0.00185	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—PTEN—meningioma	0.00185	0.00185	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—PTEN—meningioma	0.00184	0.00184	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways in Glioblastoma—AKT1—meningioma	0.00184	0.00184	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—PTEN—meningioma	0.00184	0.00184	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—PTEN—meningioma	0.00183	0.00183	CbGpPWpGaD
Trametinib—MAP2K2—TCR Signaling Pathway—AKT1—meningioma	0.00183	0.00183	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—PTEN—meningioma	0.00181	0.00181	CbGpPWpGaD
Trametinib—MAP2K1—MicroRNAs in cardiomyocyte hypertrophy—AKT1—meningioma	0.00181	0.00181	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—PTEN—meningioma	0.00181	0.00181	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—ERBB2—meningioma	0.00179	0.00179	CbGpPWpGaD
Trametinib—MAP2K1—Senescence and Autophagy in Cancer—TP53—meningioma	0.00179	0.00179	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—PTEN—meningioma	0.00174	0.00174	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—PTEN—meningioma	0.00173	0.00173	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—PTEN—meningioma	0.00173	0.00173	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—PTEN—meningioma	0.00173	0.00173	CbGpPWpGaD
Trametinib—MAP2K2—B Cell Receptor Signaling Pathway—AKT1—meningioma	0.00172	0.00172	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—PTEN—meningioma	0.00171	0.00171	CbGpPWpGaD
Trametinib—MAP2K1—TCR Signaling Pathway—AKT1—meningioma	0.00171	0.00171	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—PTEN—meningioma	0.0017	0.0017	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—PTEN—meningioma	0.00169	0.00169	CbGpPWpGaD
Trametinib—MAP2K1—Corticotropin-releasing hormone—AKT1—meningioma	0.00168	0.00168	CbGpPWpGaD
Trametinib—MAP2K2—Integrin-mediated Cell Adhesion—AKT1—meningioma	0.00168	0.00168	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—TSHB—meningioma	0.00168	0.00168	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—HES1—meningioma	0.00166	0.00166	CbGpPWpGaD
Trametinib—MAP2K2—Toll-like Receptor Signaling Pathway—AKT1—meningioma	0.00165	0.00165	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD34—meningioma	0.00165	0.00165	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	0.00164	0.00164	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—PTEN—meningioma	0.00163	0.00163	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.00163	0.00163	CbGpPWpGaD
Trametinib—MAP2K2—ErbB1 downstream signaling—AKT1—meningioma	0.00162	0.00162	CbGpPWpGaD
Trametinib—MAP2K1—B Cell Receptor Signaling Pathway—AKT1—meningioma	0.00161	0.00161	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—TP53—meningioma	0.00159	0.00159	CbGpPWpGaD
Trametinib—MAP2K2—VEGFA-VEGFR2 Pathway—AKT1—meningioma	0.00159	0.00159	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CTSL—meningioma	0.00157	0.00157	CbGpPWpGaD
Trametinib—MAP2K1—Integrin-mediated Cell Adhesion—AKT1—meningioma	0.00157	0.00157	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—TSHB—meningioma	0.00157	0.00157	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—HES1—meningioma	0.00155	0.00155	CbGpPWpGaD
Trametinib—MAP2K1—Toll-like Receptor Signaling Pathway—AKT1—meningioma	0.00155	0.00155	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD34—meningioma	0.00154	0.00154	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	0.00153	0.00153	CbGpPWpGaD
Trametinib—MAP2K1—ErbB1 downstream signaling—AKT1—meningioma	0.00151	0.00151	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by VEGF—AKT1—meningioma	0.0015	0.0015	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—TP53—meningioma	0.00149	0.00149	CbGpPWpGaD
Trametinib—MAP2K1—VEGFA-VEGFR2 Pathway—AKT1—meningioma	0.00149	0.00149	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—ERBB2—meningioma	0.00147	0.00147	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CTSL—meningioma	0.00147	0.00147	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—SMO—meningioma	0.00143	0.00143	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by VEGF—AKT1—meningioma	0.00141	0.00141	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—ERBB2—meningioma	0.00138	0.00138	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—AKT1—meningioma	0.00135	0.00135	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CST3—meningioma	0.00134	0.00134	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—SMO—meningioma	0.00134	0.00134	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—ERBB2—meningioma	0.00133	0.00133	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—TP53—meningioma	0.00131	0.00131	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of toll-like receptor signaling pathway—AKT1—meningioma	0.00129	0.00129	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—AKT1—meningioma	0.00128	0.00128	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—AKT1—meningioma	0.00126	0.00126	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—PTEN—meningioma	0.00126	0.00126	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—PDGFB—meningioma	0.00125	0.00125	CbGpPWpGaD
Trametinib—MAP2K2—BDNF signaling pathway—AKT1—meningioma	0.00125	0.00125	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CST3—meningioma	0.00125	0.00125	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—ERBB2—meningioma	0.00125	0.00125	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—TP53—meningioma	0.00123	0.00123	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—AKT1—meningioma	0.00122	0.00122	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—AKT1—meningioma	0.00121	0.00121	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—AKT1—meningioma	0.0012	0.0012	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—AKT1—meningioma	0.00119	0.00119	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—PTEN—meningioma	0.00118	0.00118	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—PDGFB—meningioma	0.00117	0.00117	CbGpPWpGaD
Trametinib—MAP2K1—BDNF signaling pathway—AKT1—meningioma	0.00117	0.00117	CbGpPWpGaD
Trametinib—MAP2K2—Insulin Signaling—AKT1—meningioma	0.00115	0.00115	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—AKT1—meningioma	0.00115	0.00115	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—AKT1—meningioma	0.00114	0.00114	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—AKT1—meningioma	0.00114	0.00114	CbGpPWpGaD
Trametinib—MAP2K2—EGF/EGFR Signaling Pathway—AKT1—meningioma	0.00114	0.00114	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—AKT1—meningioma	0.00114	0.00114	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—AKT1—meningioma	0.00113	0.00113	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—AKT1—meningioma	0.00112	0.00112	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—AKT1—meningioma	0.00111	0.00111	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.00111	0.00111	CbGpPWpGaD
Trametinib—MAP2K1—Insulin Signaling—AKT1—meningioma	0.00108	0.00108	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—AKT1—meningioma	0.00107	0.00107	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—AKT1—meningioma	0.00107	0.00107	CbGpPWpGaD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—AKT1—meningioma	0.00107	0.00107	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—AKT1—meningioma	0.00106	0.00106	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.00106	0.00106	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—AKT1—meningioma	0.00106	0.00106	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—AKT1—meningioma	0.00106	0.00106	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—AKT1—meningioma	0.00106	0.00106	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—AKT1—meningioma	0.00105	0.00105	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—AKT1—meningioma	0.00105	0.00105	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—AKT1—meningioma	0.00104	0.00104	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—AKT1—meningioma	0.00104	0.00104	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—AKT1—meningioma	0.00101	0.00101	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—AKT1—meningioma	0.000995	0.000995	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—AKT1—meningioma	0.000995	0.000995	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.000995	0.000995	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TSHB—meningioma	0.000991	0.000991	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—AKT1—meningioma	0.000986	0.000986	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—AKT1—meningioma	0.000978	0.000978	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—AKT1—meningioma	0.000973	0.000973	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—ERBB2—meningioma	0.000952	0.000952	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000942	0.000942	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—AKT1—meningioma	0.000941	0.000941	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000937	0.000937	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TSHB—meningioma	0.000928	0.000928	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—ERBB2—meningioma	0.000891	0.000891	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000882	0.000882	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ALAD—meningioma	0.000866	0.000866	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SMO—meningioma	0.000843	0.000843	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—ERBB2—meningioma	0.000841	0.000841	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PGR—meningioma	0.000808	0.000808	CbGpPWpGaD
Trametinib—MAP2K2—Disease—HES1—meningioma	0.000789	0.000789	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SMO—meningioma	0.000789	0.000789	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—ERBB2—meningioma	0.000787	0.000787	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PGR—meningioma	0.000756	0.000756	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HES1—meningioma	0.000738	0.000738	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PDGFB—meningioma	0.000731	0.000731	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—AKT1—meningioma	0.000725	0.000725	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—PTEN—meningioma	0.000717	0.000717	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PDGFB—meningioma	0.000684	0.000684	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—AKT1—meningioma	0.000678	0.000678	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PDGFB—meningioma	0.000675	0.000675	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—PTEN—meningioma	0.000671	0.000671	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PDGFB—meningioma	0.000631	0.000631	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—TSHB—meningioma	0.000558	0.000558	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HES1—meningioma	0.000553	0.000553	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HES1—meningioma	0.000517	0.000517	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—ERBB2—meningioma	0.00049	0.00049	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PDGFB—meningioma	0.000473	0.000473	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—AKT1—meningioma	0.000468	0.000468	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALAD—meningioma	0.000465	0.000465	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—ERBB2—meningioma	0.000458	0.000458	CbGpPWpGaD
Trametinib—MAP2K2—Disease—ERBB2—meningioma	0.000452	0.000452	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PDGFB—meningioma	0.000442	0.000442	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—AKT1—meningioma	0.000438	0.000438	CbGpPWpGaD
Trametinib—MAP2K1—Disease—ERBB2—meningioma	0.000423	0.000423	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PTEN—meningioma	0.000418	0.000418	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—AKT1—meningioma	0.000413	0.000413	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PTEN—meningioma	0.000391	0.000391	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—AKT1—meningioma	0.000387	0.000387	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTEN—meningioma	0.000386	0.000386	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTEN—meningioma	0.000361	0.000361	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000341	0.000341	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ERBB2—meningioma	0.000317	0.000317	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TSHB—meningioma	0.0003	0.0003	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ERBB2—meningioma	0.000296	0.000296	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PTEN—meningioma	0.00027	0.00027	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—AKT1—meningioma	0.000264	0.000264	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PTEN—meningioma	0.000253	0.000253	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—AKT1—meningioma	0.000247	0.000247	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—AKT1—meningioma	0.000241	0.000241	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—AKT1—meningioma	0.000225	0.000225	CbGpPWpGaD
Trametinib—MAP2K2—Disease—AKT1—meningioma	0.000222	0.000222	CbGpPWpGaD
Trametinib—MAP2K1—Disease—AKT1—meningioma	0.000208	0.000208	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TP53—meningioma	0.000184	0.000184	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TP53—meningioma	0.000172	0.000172	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AKT1—meningioma	0.000156	0.000156	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTEN—meningioma	0.000152	0.000152	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AKT1—meningioma	0.000146	0.000146	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AKT1—meningioma	8.76e-05	8.76e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTEN—meningioma	8.16e-05	8.16e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AKT1—meningioma	4.7e-05	4.7e-05	CbGpPWpGaD
